fbpx
Woman talking with doctor on video call.

Telemedicine in Oncology: RT Patients Report High Satisfaction

Patients receiving radiotherapy reported high satisfaction with telemedicine in their oncology consultations, according to a survey. This study, from researchers at Memorial Sloan Kettering Cancer Center, was published in the Journal of the National Comprehensive...
Advertisement

Journal Reading List

Multiple Myeloma Knowledge Hub

Risk Factors and Incidence of Acute Kidney Injury in Patients Receiving CAR-T Cell Therapy

Chimeric antigen receptor (CAR) T-cell therapy is a major advancement in the personalized treatment of hematological malignancies, and it is being explored in the...

The Role of Medical Imaging in Managing Patients Receiving CAR T-Cell Therapy

Chimeric antigen receptor (CAR) T-cell therapy has provided a novel, effective treatment option for patients with relapsed or refractory non-Hodgkin lymphoma. However, many patients...
blurred figures of doctors and nurses in a hospital corridor

Study Identifies Cytokines Potentially Involved in Neurotoxicity Syndrome After CAR T-Cell Therapy

Chimeric antigen receptor (CAR) T-cell therapy is a promising new option for treatment of hematologic malignancies, but many patients who receive CAR T-cell therapy...

Recent Review Shows Promising Future for CAR T-Cell Therapy in Lung Cancer Treatment

Early research did not show that chimeric antigen receptor (CAR) T-cell therapy is effective against lung cancer, a solid tumor, despite its effectiveness in...
image of a newspaper

Response to COVID-19 Vaccine Variable in Multiple Myeloma Patients

Patients with multiple myeloma (MM) mount a highly variable antibody response after receipt of a two-dose mRNA COVID-19 vaccination regimen, according to a study...

Researchers Encourage Exploration of Dual-Targeted CAR T-Cell Treatment in Multiple Myeloma

Targeted immunotherapy is a very promising strategy in the treatment of multiple myeloma (MM). Specifically, clinical trials using chimeric antigen receptor (CAR) T-cells to...

Electroencephalography Useful for Seizure Detection in Children and Young Adults Receiving CAR T-Cell Therapy

Immune effector cell–associated neurotoxicity syndrome is a clinical and neuropsychiatric syndrome that can occur in the days to weeks following administration of certain types...

Research Group Publishes Recommendations on Infection in Patients Receiving CAR T-Cell Therapy

Chimeric antigen receptor (CAR) T-cell therapy is a rapidly emerging treatment option for patients with B-cell malignancies. Many patients who receive CAR T-cell therapy...
Advertisement
Advertisement